Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Deciphering the Core Metabolites of Fanconi Anemia by Using a Multi-Omics Composite Network

  • Xie, Xiaobin (Department of Pathology, School of Basic Medical Science, Guangzhou Medical University) ;
  • Chen, Xiaowei (Department of Hematology, Guangzhou First People's Hospital, South China University of Technology)
  • Received : 2021.06.11
  • Accepted : 2021.12.20
  • Published : 2022.03.28
Download PDF
⟨ Previous Next ⟩

Abstract

Deciphering the metabolites of human diseases is an important objective of biomedical research. Here, we aimed to capture the core metabolites of Fanconi anemia (FA) using the bioinformatics method of a multi-omics composite network. Based on the assumption that metabolite levels can directly mirror the physiological state of the human body, we used a multi-omics composite network that integrates six types of interactions in humans (gene-gene, disease phenotype-phenotype, disease-related metabolite-metabolite, gene-phenotype, gene-metabolite, and metabolite-phenotype) to procure the core metabolites of FA. This method is applicable in predicting and prioritizing disease candidate metabolites and is effective in a network without known disease metabolites. In this report, we first singled out the differentially expressed genes upon different groups that were related with FA and then constructed the multi-omics composite network of FA by integrating the aforementioned six networks. Ultimately, we utilized random walk with restart (RWR) to screen the prioritized candidate metabolites of FA, and meanwhile the co-expression gene network of FA was also obtained. As a result, the top 5 metabolites of FA were tenormin (TN), guanosine 5'-triphosphate, guanosine 5'-diphosphate, triphosadenine (DCF) and adenosine 5'-diphosphate, all of which were reported to have a direct or indirect relationship with FA. Furthermore, the top 5 co-expressed genes were CASP3, BCL2, HSPD1, RAF1 and MMP9. By prioritizing the metabolites, the multi-omics composite network may provide us with additional indicators closely linked to FA.

Keywords

Acknowledgement

This work was supported by the Medical Scientific Research Foundation of Guangdong Province (A2020361).

References

  1. Baltierra D, Harper T, Jones MP, Nau KC. 2015. Hematologic disorders: Bone marrow failure. FP Essent. 433: 21-26.
  2. Yang N, Chen J, Zhang H, Dai Z, Yao H, Ma X, et al. 2017. Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naive aplastic anemia: a systematic review and meta-analysis. Annal. Hematol. 96: 2031-2043. https://doi.org/10.1007/s00277-017-3136-1
  3. Liu C, Zheng M, Zhang T, Fu R, Wang H, Wang T, et al. 2017. TRAIL in CD8+ T cells from patients with severe aplastic anemia. Int. J. Hematol. 106: 490-499. https://doi.org/10.1007/s12185-017-2279-0
  4. Steele JM, Sung L, Klaassen R, Fernandez CV, Yanofsky R, Wu J, et al. 2006. Disease progression in recently diagnosed patients with inherited marrow failure syndromes: a Canadian Inherited Marrow Failure Registry (CIMFR) report. Pediatr. Blood Cancer 47: 918-925. https://doi.org/10.1002/pbc.20876
  5. Juarez-Rendon KJ, Rivera Sanchez G, Reyes-Lopez M, Garcia-Ortiz JE, Bocanegra-Garcia V, Guardiola-Avila I, et al. 2017. Alopecia areata. current situation and perspectives. Arch. Argent. Pediatr. 115: e404-e411.
  6. Reppe S, Datta HK, Gautvik KM. 2017. Omics analysis of human bone to identify genes and molecular networks regulating skeletal remodeling in health and disease. Bone 101: 88-95. https://doi.org/10.1016/j.bone.2017.04.012
  7. Johnson CH, Ivanisevic J, Siuzdak G. 2016. Metabolomics: beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17: 451-459. https://doi.org/10.1038/nrm.2016.25
  8. Stewart JL, Besenyi GB, Williams LB, Burt V, Anglin JC, Ghamande SA, et al. 2017. Healthy lifestyle intervention for African American uterine cancer survivors: Study protocol. Contemp. Clin. Trials Commun. 8: 11-17. https://doi.org/10.1016/j.conctc.2017.08.011
  9. Yao Q, Xu Y, Yang H, Shang D, Zhang C, Zhang Y, et al. 2015. Global prioritization of disease candidate metabolites based on a multi-omics composite network. Sci. Rep. 5: 17201. https://doi.org/10.1038/srep17201
  10. Driel MAV, Bruggeman J, Vriend G, Han GB, Leunissen JAM. 2006. A text-mining analysis of the human phenome. Eur. J. Hum. Genet. 14: 535-542. https://doi.org/10.1038/sj.ejhg.5201585
  11. Simon-Manso Y, Lowenthal MS, Kilpatrick LE, Sampson ML, Telu KH, Rudnick PA, et al. 2013. Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. Anal. Chem. 85: 11725-11731. https://doi.org/10.1021/ac402503m
  12. Moreno-Sanchez R, Saavedra E, Gallardo-Perez JC, Rumjanek FD, Rodriguez-Enriquez S. 2016. Understanding the cancer cell phenotype beyond the limitations of current omics analyses. FEBS J. 283: 54-73. https://doi.org/10.1111/febs.13535
  13. Unni S, Yao Y, Milne N, Gunning K, Curtis JR, Lafleur J. 2015. An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database. Osteoporos. Int. 26: 581-587. https://doi.org/10.1007/s00198-014-2899-7
  14. Hocht C, F MB, J SDM, Santander Plantamura Y, C AT, A HP. 2017. What is the real efficacy of beta-blockers for the treatment of essential hypertension? Curr. Pharm. Design 23: 4658-4677.
  15. Shang D, Li C, Yao Q, Yang H, Xu Y, Han J, et al. 2014. Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways. PLoS One 9: e104934. https://doi.org/10.1371/journal.pone.0104934
  16. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, et al. 2005. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437: 1173-1178. https://doi.org/10.1038/nature04209